OptimiTM-03.jpg
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
22 mai 2024 08h30 HE | Optimi Health Corp.
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
xylo.jpg
Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany
21 mai 2024 08h56 HE | Xylo Technologies Ltd.
TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announces...
Figure # 1
Bocana Resources Corp. Kori Kollo Review – Bolivia
17 avr. 2024 15h58 HE | Bocana Resources Corp.
CALGARY, Alberta, April 17, 2024 (GLOBE NEWSWIRE) -- Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) ("Bocana" or the "Company") – is pleased to provide additional information with respect to...
Screenshot 2023-05-10 at 9.00.51 AM.png
Power Leaves Corp. Enters Into LOI for RTO; Targets Public Listing in H1 2024
27 mars 2024 07h45 HE | Power Leaves Corp.
Upon Completion of a Successful Listing, PLC Would Become the First Publicly Traded Decocainized-coca Derivative Manufacturer & Distributor  TORONTO, Ontario, March 27, 2024 (GLOBE NEWSWIRE)...
Btab_logo.png
Btab Ecommerce Group Signs LOI to Merge with Integrated Wellness Acquisition Corp
15 févr. 2024 09h34 HE | Btab Group
Btab Ecommerce Group Signs LOI to Merge with Integrated Wellness Acquisition Corp
Logo.png
Banzai Executes LOI to Acquire Boast, a Seamless Platform for Automating Video Testimonial Marketing
22 janv. 2024 08h30 HE | Banzai International, Inc.
Banzai today announced that it has signed a non-binding letter of intent to acquire Boast, an all-in-one platform for video-based customer testimonials.
Logo.png
Banzai Executes LOI to Acquire Cliently, An AI-Driven Sales Engagement Platform
18 janv. 2024 08h30 HE | Banzai International, Inc.
Banzai, a leading marketing technology company, today announced that it has signed a non-binding letter of intent to acquire Cliently.
Picture1.png
Jeffs' Brands to Invest in a Remote Wireless Power Transmission Technology
20 déc. 2023 07h26 HE | Jeffs' Brands Ltd
The Company signed a non-binding letter of intent to invest $2.5 million for a 70% stake in a new company to be incorporated that will develop laser- based charging solutions for drones and unmanned...
Picture1.png
Jeffs' Brands Signs a Non-Binding Letter of Intent to Invest in a Remote Wireless Electric Charging Technology Company
15 déc. 2023 07h24 HE | Jeffs' Brands Ltd
The Company will hold a 70% interest in a new company to be incorporated that will develop laser- based charging solutions for drones and unmanned aircrafts Tel Aviv, Israel, Dec. 15, 2023 (GLOBE...
Algernon Logo 1.png
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
22 nov. 2023 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...